SG Americas Securities’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13K | Sell |
13,814
-54,198
| -80% | -$51K | ﹤0.01% | 2485 |
|
|
2025
Q1 | $31K | Buy |
68,012
+12,704
| +23% | +$5.79K | ﹤0.01% | 2925 |
|
|
2024
Q4 | $41K | Buy |
55,308
+9,218
| +20% | +$6.83K | ﹤0.01% | 2600 |
|
|
2024
Q3 | $72K | Buy |
46,090
+23,893
| +108% | +$37.3K | ﹤0.01% | 2803 |
|
|
2024
Q2 | $37K | Buy |
22,197
+2,928
| +15% | +$4.88K | ﹤0.01% | 2343 |
|
|
2024
Q1 | $46K | Sell |
19,269
-24,524
| -56% | -$58.5K | ﹤0.01% | 2444 |
|
|
2023
Q4 | $67K | Sell |
43,793
-14,914
| -25% | -$22.8K | ﹤0.01% | 2606 |
|
|
2023
Q3 | $64K | Buy |
+58,707
| New | +$64K | ﹤0.01% | 2603 |
|
|
2023
Q2 | – | Sell |
-37,689
| Closed | -$92K | – | 2438 |
|
|
2023
Q1 | $92K | Buy |
37,689
+12,636
| +50% | +$30.8K | ﹤0.01% | 2680 |
|
|
2022
Q4 | $48K | Sell |
25,053
-9,536
| -28% | -$18.3K | ﹤0.01% | 2577 |
|
|
2022
Q3 | $83K | Sell |
34,589
-878
| -2% | -$2.11K | ﹤0.01% | 2596 |
|
|
2022
Q2 | $66K | Buy |
35,467
+1,747
| +5% | +$3.25K | ﹤0.01% | 2928 |
|
|
2022
Q1 | $70K | Buy |
33,720
+13,876
| +70% | +$28.8K | ﹤0.01% | 2486 |
|
|
2021
Q4 | $78K | Sell |
19,844
-40,148
| -67% | -$158K | ﹤0.01% | 2820 |
|
|
2021
Q3 | $289K | Sell |
59,992
-23,961
| -29% | -$115K | ﹤0.01% | 2733 |
|
|
2021
Q2 | $385K | Buy |
+83,953
| New | +$385K | ﹤0.01% | 1861 |
|
|
2021
Q1 | – | Sell |
-19,786
| Closed | -$68K | – | 2963 |
|
|
2020
Q4 | $68K | Buy |
+19,786
| New | +$68K | ﹤0.01% | 2724 |
|
|
2020
Q3 | – | Sell |
-22,259
| Closed | -$44K | – | 2579 |
|
|
2020
Q2 | $44K | Buy |
22,259
+5,767
| +35% | +$11.4K | ﹤0.01% | 3076 |
|
|
2020
Q1 | $32K | Buy |
+16,492
| New | +$32K | ﹤0.01% | 2737 |
|
|
2017
Q4 | – | Sell |
-16,779
| Closed | -$206K | – | 2793 |
|
|
2017
Q3 | $206K | Buy |
16,779
+3,313
| +25% | +$40.7K | ﹤0.01% | 2230 |
|
|
2017
Q2 | $222K | Sell |
13,466
-813
| -6% | -$13.4K | ﹤0.01% | 2072 |
|
|
2017
Q1 | $205K | Sell |
14,279
-24,976
| -64% | -$359K | ﹤0.01% | 2149 |
|
|
2016
Q4 | $543K | Buy |
+39,255
| New | +$543K | ﹤0.01% | 1483 |
|
|
2016
Q2 | – | Sell |
-11,648
| Closed | -$139K | – | 2343 |
|
|
2016
Q1 | $139K | Buy |
11,648
+4,037
| +53% | +$48.2K | ﹤0.01% | 2126 |
|
|
2015
Q4 | $101K | Buy |
+7,611
| New | +$101K | ﹤0.01% | 2063 |
|
|
2015
Q1 | – | Sell |
-9,276
| Closed | -$59K | – | 2397 |
|
|
2014
Q4 | $59K | Sell |
9,276
-5,588
| -38% | -$35.5K | ﹤0.01% | 2651 |
|
|
2014
Q3 | $147K | Buy |
14,864
+8,483
| +133% | +$83.9K | ﹤0.01% | 1872 |
|
|
2014
Q2 | $72K | Buy |
+6,381
| New | +$72K | ﹤0.01% | 2037 |
|
|
2014
Q1 | – | Sell |
-6,816
| Closed | -$86K | – | 2186 |
|
|
2013
Q4 | $86K | Sell |
6,816
-170
| -2% | -$2.15K | ﹤0.01% | 2117 |
|
|
2013
Q3 | $116K | Buy |
6,986
+3,014
| +76% | +$50K | ﹤0.01% | 2269 |
|
|
2013
Q2 | $60K | Buy |
+3,972
| New | +$60K | ﹤0.01% | 1791 |
|